In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AOP gets European rights to Cardiome Pharma's Brinavess

Executive Summary

AOP Orphan Pharmaceuticals AG has licensed certain European rights to Cardiome Pharma Corp.’s (cardiovascular drugs) Brinavess (vernakalant). The deal is for an initial three years, but is renewable annually thereafter.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies